1
|
Malagoli A, Albini A, Benfari G, Ilardi F, Lisi M, Mandoli GE, Pastore MC, Sperlongano S, Cameli M, D'Andrea A. Arrhythmic mitral valve prolapse: a practical approach for asymptomatic patients. Eur Heart J Cardiovasc Imaging 2024; 25:293-301. [PMID: 38061000 DOI: 10.1093/ehjci/jead332] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/20/2023] [Revised: 11/24/2023] [Accepted: 11/28/2023] [Indexed: 02/24/2024] Open
Abstract
Mitral valve prolapse (MVP) is usually regarded as a benign condition though the proportion of patients with a life-threatening arrhythmic MVP form remains undefined. Recently, an experts' consensus statement on arrhythmic MVP has proposed approaches for risk stratification across the spectrum of clinical manifestation. However, sudden cardiac death may be the first presentation, making clinicians focused to early unmasking this subset of asymptomatic patients. Growing evidence on the role of cardiac imaging in the in-deep stratification pathway has emerged in the last decade. Pathology findings have suggested the fibrosis of papillary muscles and inferobasal left ventricular wall as the malignant hallmark. Cardiac magnetic resonance, while of limited availability, allows the identification of this arrhythmogenic substrate. Therefore, speckle-tracking echocardiography may be a gateway to prompt referring patients to further advanced imaging investigation. Our review aims to summarize the phenotypic features linked to the arrhythmic risk and to propose an image-based algorithm intended to help stratifying asymptomatic MVP patients.
Collapse
Affiliation(s)
- Alessandro Malagoli
- Division of Cardiology, Nephro-Cardiovascular Department, Baggiovara Hospital, University of Modena and Reggio Emilia, 1355 Pietro Giardini Street, Modena 41126, Italy
| | - Alessandro Albini
- Division of Cardiology, Department of Cardiac, Thoracic and Vascular diseases, IRCCS San Gerardo dei Tintori Foundation, Monza, Italy
| | - Giovanni Benfari
- Division of Cardiology, Department of Medicine, University of Verona, Verona, Italy
| | - Federica Ilardi
- Department of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy
| | - Matteo Lisi
- Department of Cardiovascular Disease-AUSL Romagna, Division of Cardiology, Ospedale S. Maria delle Croci, Ravenna, Italy
| | - Giulia Elena Mandoli
- Department of Medical Biotechnologies, Division of Cardiology, University of Siena, Siena, Italy
| | - Maria Concetta Pastore
- Department of Medical Biotechnologies, Division of Cardiology, University of Siena, Siena, Italy
| | - Simona Sperlongano
- Division of Cardiology, Department of Translational Medical Sciences, University of Campania Luigi Vanvitelli, Naples, Italy
| | - Matteo Cameli
- Department of Medical Biotechnologies, Division of Cardiology, University of Siena, Siena, Italy
| | - Antonello D'Andrea
- Division of Cardiology, Department of Translational Medical Sciences, University of Campania Luigi Vanvitelli, Naples, Italy
- Department of Cardiology, Umberto I Hospital, Nocera Inferiore, Italy
| |
Collapse
|
2
|
Albini A, Passiatore M, Leo G, Imberti JF, Valenti AC, Coppi F, Sgura FA, Boriani G. 478 VENTRICULAR AND ATRIAL REMODELING AFTER EDGE-TO-EDGE TRANS-CATHETER MITRAL VALVE REPAIR: A PILOT STUDY. Eur Heart J Suppl 2022. [DOI: 10.1093/eurheartjsupp/suac121.342] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
Abstract
Abstract
Background
Percutaneous mitral valve repair (PMVR) is an established therapy for mitral regurgitation (MR) in patients at high risk for surgical treatment. The aim of this study was to determine the impact of PMVR on left and right ventricular (LV, RV) and left and right atrial (LA, RA) remodelling according to the mechanism of MR and history of atrial fibrillation (AF).
Methods and results
Twenty-four patients (mean age 78.54 years ± 7.64 SD; 62.5% males) undergoing PMVR at our centre were prospectively enrolled. All the patients underwent echocardiography 1.6 ± 0.9 months before the procedure and after 5.7 ± 3.5 months; functional MR accounted for 54% of cases. Compared to baseline, a statistically significant improvement in LV end-diastolic diameter (LVEDD), LV indexed mass (ILVM), LV end-diastolic and end-systolic volumes (LVEDV, LVESV), indexed LA volume (iLAV) and morpho-functional RV parameters was recorded. LVEDD and LVEDV improved in primary MR cohort whereas in secondary MR a significant reduction in LVEDV and LVESV with a nonsignificant improvement in ejection fraction were found. (Table 1) LA positive remodelling was found in organic MR with a trend toward ameliorated function; in functional MR, with more dilated and dysfunctional LA, no significant improvement was found. (Table 1) Furthermore, a significant reduction of LA volumetry was detected only in patients without history of AF (AF baseline 51.4 mL/m2 IQR 45.6-62.5 mL/m2 f-u 48.9 mL/m2 IQR 42.9-59.2 mL/m2; p=0.101; no AF baseline 43.5 mL/m2 IQR 34.2-60.5 mL/m2 f-u 42.0 mL/m2 IQR 32.0-46.2 mL/m2; p=0.012). As regards right sections, the most relevant positive remodeling was obtained in patients with functional MR with a baseline poorer RV function and more severe RA and RV dilation. (Table 1)
Conclusion
At mid-term follow-up after PMVR, a positive cardiac remodeling is detected in atrial and ventricular chambers also involving the right sections. To deliver a tailored intervention, MR mechanism and history of AF should be considered in view of the impact on remodeling process.
Collapse
Affiliation(s)
- Alessandro Albini
- Cardiology Division, Department Of Biomedical, Metabolic And Neural Sciences, University Of Modena And Reggio Emilia, Policlinico Di Modena , Modena , Italy
| | - Matteo Passiatore
- Cardiology Division, Department Of Biomedical, Metabolic And Neural Sciences, University Of Modena And Reggio Emilia, Policlinico Di Modena , Modena , Italy
| | - Giulio Leo
- Cardiology Division, Department Of Biomedical, Metabolic And Neural Sciences, University Of Modena And Reggio Emilia, Policlinico Di Modena , Modena , Italy
| | - Jacopo Francesco Imberti
- Cardiology Division, Department Of Biomedical, Metabolic And Neural Sciences, University Of Modena And Reggio Emilia, Policlinico Di Modena , Modena , Italy
- Liverpool Centre For Cardiovascular Science, University Of Liverpool And Liverpool Heart & Chest Hospital , Liverpool, United Kingdom
| | - Anna Chiara Valenti
- Cardiology Division, Department Of Biomedical, Metabolic And Neural Sciences, University Of Modena And Reggio Emilia, Policlinico Di Modena , Modena , Italy
| | - Francesca Coppi
- Cardiology Division, Department Of Biomedical, Metabolic And Neural Sciences, University Of Modena And Reggio Emilia, Policlinico Di Modena , Modena , Italy
| | - Fabio Alfredo Sgura
- Cardiology Division, Department Of Biomedical, Metabolic And Neural Sciences, University Of Modena And Reggio Emilia, Policlinico Di Modena , Modena , Italy
| | - Giuseppe Boriani
- Cardiology Division, Department Of Biomedical, Metabolic And Neural Sciences, University Of Modena And Reggio Emilia, Policlinico Di Modena , Modena , Italy
| |
Collapse
|
3
|
Bonini N, Albini A, Venturelli A, Maisano A, Luli J, Vitolo M, Imberti JF, Valenti AC, Righelli I, Cataldo P, Muto F, Tosetti A, Boriani G. 559 SACUBITRIL/VALSARTAN IN “REAL WORLD“ HEART FAILURE PATIENTS: FOCUS ON RENAL FUNCTION AND DRUG TITRATION. Eur Heart J Suppl 2022. [DOI: 10.1093/eurheartjsupp/suac121.433] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
Abstract
Abstract
Background and aim of the study
There is a rising interest in real-world data about Sacubitril/Valsartan (Sa/Va) treatment, especially for the renal outcomes in patients treated with low (24/26 mg bid), mid (49/51 mg bid) and high (97/103 mg bid) dosages. Our aim was to assess the changes of the estimated glomerular filtration rate (eGFR) and the association of chronic kidney disease (CKD) with the titration of Sa/Va in a cohort of ambulatory HF patients with reduced ejection fraction (HFrEF) enrolled in a monocentric registry.
Methods
CKD was defined with an eGFR < 60ml/min, and the patients were stratified according to the CKD stage with the CKD-EPI formula. After one year of follow-up, Sa/Va titration was defined as the passage from a lower to a higher dose. We performed a descriptive analysis assessing the improvement or worsening of the eGFR, defined as ≥ or ≤ 20% from the eGFR baseline, and the association of CKD status and other clinical factors (age, male biological sex, BMI, systolic blood pressure, NYHA≥2) with Sa/Va titration.
Results
Among the original 158 patients, 139 (87.9%) patients with serial creatinine values were included in this analysis. Patients had a median age of 66 years [IQR 56-71], 16.5% were female, with a median EF of 30% [IQR 28-35], median NYHA class was 2 [IQR 2-3], 73 (52.5%) had an ischemic aetiology, and 77 (55.4%) and 39 (28.1%) patients had a prior ICD and CRT-P/D implantation, respectively. Prescribed dosages of Sa/Va were low for 96 (69.1%) patients, mid for 36 (25.9%) and high for 6 (4.3%) patients. Fifty-eight (41.7%) patients had CKD with an eGFR median of 48.1 [IQR 41.8-53.0]; forty of them (28.8%) were in stage IIIA, and eighteen of them (12.9%) were in stage IIIB. Among this group, the prescribed dosage of Sa/Va was low for thirty-nine (67.2%) patients, mid for seventeen (29.3%) patients, and high for two (3.4%) patients. After one year of follow-up, in the whole cohort, clinicians titrated the dose of Sa/Va in twenty-two (15.8%) patients, and in a multivariable logistic regression analysis, CKD was inversely associated with the titration of the Sa/Va [Figure]. Five (3.6%) patients improved renal function, while twenty-two (15.8%) patients experienced decreased renal function. Among those who tolerated the titration, none had an improvement of the eGFR ≥20%. Among the CKD patients’ subgroup, seven (12.1%) received a titrated dose of Sa/Va; two (3.4%) patients improved renal function, and twelve (20.7%) patients worsened it, but no Sa/Va discontinuations were detected. As with the whole cohort, in this group no patients improved their renal function and titrated the Sa/Va dose.
Conclusions
After one year of follow-up, in a contemporary cohort of HFrEF Italian patients treated with Sa/Va, CKD was a predictor of no-titration of Sa/Va. Improved eGFR ≥ 20% from the baseline occurred in around 4% of patients in the general cohort and CKD subgroup, but not in conjunction with Sa/Va titration. Although 20.7% of CKD patients worsened their renal function, this did not result in Sa/Va discontinuation.
Figure.
Collapse
|
4
|
Barbieri A, Albini A, Chiusolo S, Forzati N, Laus V, Maisano A, Muto F, Passiatore M, Stuani M, Torlai Triglia L, Vitolo M, Ziveri V, Boriani G. Three-Dimensional Automated, Machine-Learning-Based Left Heart Chamber Metrics: Associations with Prevalent Vascular Risk Factors and Cardiovascular Diseases. J Clin Med 2022; 11:jcm11247363. [PMID: 36555980 PMCID: PMC9782505 DOI: 10.3390/jcm11247363] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/16/2022] [Revised: 12/08/2022] [Accepted: 12/09/2022] [Indexed: 12/14/2022] Open
Abstract
Background. Three-dimensional transthoracic echocardiography (3DE) powered by artificial intelligence provides accurate left chamber quantification in good accordance with cardiac magnetic resonance and has the potential to revolutionize our clinical practice. Aims. To evaluate the association and the independent value of dynamic heart model (DHM)-derived left atrial (LA) and left ventricular (LV) metrics with prevalent vascular risk factors (VRFs) and cardiovascular diseases (CVDs) in a large, unselected population. Materials and Methods. We estimated the association of DHM metrics with VRFs (hypertension, diabetes) and CVDs (atrial fibrillation, stroke, ischemic heart disease, cardiomyopathies, >moderate valvular heart disease/prosthesis), stratified by prevalent disease status: participants without VRFs or CVDs (healthy), with at least one VRFs but without CVDs, and with at least one CVDs. Results. We retrospectively included 1069 subjects (median age 62 [IQR 49−74]; 50.6% women). When comparing VRFs with the healthy, significant difference in maximum and minimum indexed atrial volume (LAVi max and LAVi min), left atrial ejection fraction (LAEF), left ventricular mass/left ventricular end-diastolic volume ratio, and left ventricular global function index (LVGFI) were recorded (p < 0.05). In the adjusted logistic regression, LAVi min, LAEF, LV ejection fraction, and LVGFI showed the most robust association (OR 3.03 [95% CI 2.48−3.70], 0.45 [95% CI 0.39−0.51], 0.28 [95% CI 0.22−0.35], and 0.22 [95% CI 0.16−0.28], respectively, with CVDs. Conclusions. The present data suggested that novel 3DE left heart chamber metrics by DHM such as LAEF, LAVi min, and LVGFI can refine our echocardiographic disease discrimination capacity.
Collapse
Affiliation(s)
- Andrea Barbieri
- Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena, 41125 Modena, Italy
- Correspondence:
| | - Alessandro Albini
- Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena, 41125 Modena, Italy
| | - Simona Chiusolo
- Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena, 41125 Modena, Italy
| | - Nicola Forzati
- Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena, 41125 Modena, Italy
| | - Vera Laus
- Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena, 41125 Modena, Italy
| | - Anna Maisano
- Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena, 41125 Modena, Italy
| | - Federico Muto
- Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena, 41125 Modena, Italy
| | - Matteo Passiatore
- Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena, 41125 Modena, Italy
| | - Marco Stuani
- Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena, 41125 Modena, Italy
| | - Laura Torlai Triglia
- Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena, 41125 Modena, Italy
| | - Marco Vitolo
- Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena, 41125 Modena, Italy
- 2 Clinical and Experimental Medicine Ph.D. Program, University of Modena and Reggio Emilia, 41121 Modena, Italy
| | - Valentina Ziveri
- Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena, 41125 Modena, Italy
| | - Giuseppe Boriani
- Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena, 41125 Modena, Italy
| |
Collapse
|
5
|
Albini A, Passiatore M, Imberti JF, Valenti AC, Leo G, Vitolo M, Coppi F, Sgura FA, Boriani G. Ventricular and Atrial Remodeling after Transcatheter Edge-to-Edge Repair: A Pilot Study. J Pers Med 2022; 12:jpm12111916. [PMID: 36422092 PMCID: PMC9696184 DOI: 10.3390/jpm12111916] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2022] [Revised: 11/11/2022] [Accepted: 11/14/2022] [Indexed: 11/18/2022] Open
Abstract
Background: The aim of this study was to determine the impact of transcatheter edge-to-edge repair (TEER) on left and right ventricular (LV, RV) and left and right atrial (LA, RA) remodeling according to the mechanism of mitral regurgitation (MR) and history of atrial fibrillation (AF). Methods: Twenty-four patients (mean age 78.54 years ± 7.64 SD; 62.5% males) underwent TEER at our center. All the patients underwent echocardiography 1.6 ± 0.9 months before the procedure and after 5.7 ± 3.5 months; functional MR accounted for 54% of cases. Results: Compared to baseline, a statistically significant improvement in LV end-diastolic diameter (LVEDD), LV indexed mass (ILVM), LV end-diastolic and end-systolic volumes (LVEDV, LVESV), indexed LA volume (iLAV), and morpho-functional RV parameters was recorded. LVEDD and LVEDV improved in primary MR cohort, whereas in secondary MR, a significant reduction in LVEDV and LVESV was found without a significant functional improvement. LA reverse remodeling was found in organic MR with a trend toward ameliorated function. Furthermore, a significant reduction of LA volumetry was detected only in patients without history of AF (AF baseline 51.4 mL/m2 IQR 45.6–62.5 mL/m2 f-u 48.9 mL/m2 IQR 42.9–59.2 mL/m2; p = 0.101; no AF baseline 43.5 mL/m2 IQR 34.2–60.5 mL/m2 f-u 42.0 mL/m2 IQR 32.0–46.2 mL/m2; p = 0.012). As regards right sections, the most relevant reverse remodeling was obtained in patients with functional MR with a baseline poorer RV function and more severe RA and RV dilation. Conclusion: TEER induces reverse remodeling involving both left and right chambers at mid-term follow-up. To deliver a tailored intervention, MR mechanism and history of AF should be considered in view of the impact on remodeling process.
Collapse
Affiliation(s)
- Alessandro Albini
- Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena, 41124 Modena, Italy
| | - Matteo Passiatore
- Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena, 41124 Modena, Italy
| | - Jacopo Francesco Imberti
- Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena, 41124 Modena, Italy
- Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, 41121 Modena, Italy
| | - Anna Chiara Valenti
- Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena, 41124 Modena, Italy
| | - Giulio Leo
- Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena, 41124 Modena, Italy
| | - Marco Vitolo
- Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena, 41124 Modena, Italy
- Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, 41121 Modena, Italy
| | - Francesca Coppi
- Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena, 41124 Modena, Italy
| | - Fabio Alfredo Sgura
- Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena, 41124 Modena, Italy
| | - Giuseppe Boriani
- Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena, 41124 Modena, Italy
- Correspondence:
| |
Collapse
|
6
|
Carletti R, Galvani M, Gardini E, De Vita M, Dallaserra C, Vizzuso A, Ottani F, Campacci F, Grosseto D, Di Gianuario G, Rinaldi G, Vecchio S, Mantero F, Mellini L, Albini A, Mughetti M, Gardelli G, Piciucchi S. P397 PROGNOSTIC VALUE OF CORONARY CALCIUM IN PATIENTS WITH COVID–19 AND SUSPECTED INTERSTITIAL PNEUMONIA: A CASE–CONTROL STUDY. Eur Heart J Suppl 2022. [PMCID: PMC9384032 DOI: 10.1093/eurheartj/suac012.383] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
Background Short–term prognosis of SARS–CoV2 infection is mainly conditioned by the extent and severity of COVID–19 interstitial pneumonia. Coexistence of cardiac disease is however important and independently associated with an adverse outcome. Coronary calcium (CAC), detected at the time of chest computed tomography, can be a useful prognostic tool, as suggested by some cohort studies. Material and Methods We performed a retrospective, multi–centre, case–control (1:2) study in 195 COVID–19 patients admitted from 01–03–2020 to 30–04–2020. Cases were consecutive patients died within 30 days or admitted to the Intensive Care Units for invasive ventilation during the hospitalization (primary outcome measure). Controls were age– and sex–matched patients surviving until 30 days without need for invasive ventilation. For each case, we selected two controls, matched by age and sex dividing cases in age strata of 10 years, assuring within each age stratum twice the number of controls with an identical gender proportion. CAC estimation was performed with a with a semi–quantitative score (0 to 30) based on 10 segments and 4 degrees of severity of the calcification. Estimation of interstitial pneumonia, was similarly performed with a semi–quantitative score (from 0 to 20), based on 5 lobes and 5 degrees of severity of interstitial involvement. CT scans were acquired according to a standard protocol for non–cardio–synchronized chest CT, always on a multi–detector scanner with at least 16 layers. Results The mean CAC value in cases was significantly higher (p = 0.001) compared to controls: 5,52±1,38 vs 3,28±0,54 (mean value ± 95% CI). The percentage of cases with moderate–severe CAC was significantly higher (p = 0.013) compared to controls (41.5% vs 22.8%, OR 2.27 95% CI 1.20–4.29; primary end–point of the study). In multivariate analysis, independent predictors of outcome were (in descending order): interstitial pneumonia severity score (Wald 8.143, p = 0.004), CC score (Wald 5.569, p = 0.018), and the LDH value on admission (Wald 3.335, p = 0.034). Conclusions In our case–control study, the severity and extent of CAC is the main prognostic factor for the occurrence of adverse clinical outcome, beside the severity of interstitial pneumonia. These data suggest that a semi–quantitative estimation of CAC, feasible on any CT detector without the need of dedicated software, is clinically useful for the prognostic assessment of patients with COVID–19 interstitial pneumonia.
Collapse
Affiliation(s)
- R Carletti
- UOC CARDIOLOGIA FORLÌ, DIPARTIMENTO CARDIOVASCOLARE, AUSL ROMAGNA, FORLÌ; UOC RADIOLOGIA FORLÌ, DIPARTIMENTO DELLE IMMAGINI, AUSL ROMAGNA, FORLÌ; UNITÀ DI RICERCA CARDIOVASCOLARE, FONDAZIONE SACCO, FORLÌ; UOC CARDIOLOGIA RIMINI, DIPARTIMENTO CARDIOVASCOLARE, AUSL ROMAGNA, RIMINI; UOC RADIOLOGIA RIMINI, DIPARTIMENTO DELLE IMMAGINI, AUSL ROMAGNA, RIMINI; UOC CARDIOLOGIA RAVENNA, DIPARTIMENTO CARDIO
| | - M Galvani
- UOC CARDIOLOGIA FORLÌ, DIPARTIMENTO CARDIOVASCOLARE, AUSL ROMAGNA, FORLÌ; UOC RADIOLOGIA FORLÌ, DIPARTIMENTO DELLE IMMAGINI, AUSL ROMAGNA, FORLÌ; UNITÀ DI RICERCA CARDIOVASCOLARE, FONDAZIONE SACCO, FORLÌ; UOC CARDIOLOGIA RIMINI, DIPARTIMENTO CARDIOVASCOLARE, AUSL ROMAGNA, RIMINI; UOC RADIOLOGIA RIMINI, DIPARTIMENTO DELLE IMMAGINI, AUSL ROMAGNA, RIMINI; UOC CARDIOLOGIA RAVENNA, DIPARTIMENTO CARDIO
| | - E Gardini
- UOC CARDIOLOGIA FORLÌ, DIPARTIMENTO CARDIOVASCOLARE, AUSL ROMAGNA, FORLÌ; UOC RADIOLOGIA FORLÌ, DIPARTIMENTO DELLE IMMAGINI, AUSL ROMAGNA, FORLÌ; UNITÀ DI RICERCA CARDIOVASCOLARE, FONDAZIONE SACCO, FORLÌ; UOC CARDIOLOGIA RIMINI, DIPARTIMENTO CARDIOVASCOLARE, AUSL ROMAGNA, RIMINI; UOC RADIOLOGIA RIMINI, DIPARTIMENTO DELLE IMMAGINI, AUSL ROMAGNA, RIMINI; UOC CARDIOLOGIA RAVENNA, DIPARTIMENTO CARDIO
| | - M De Vita
- UOC CARDIOLOGIA FORLÌ, DIPARTIMENTO CARDIOVASCOLARE, AUSL ROMAGNA, FORLÌ; UOC RADIOLOGIA FORLÌ, DIPARTIMENTO DELLE IMMAGINI, AUSL ROMAGNA, FORLÌ; UNITÀ DI RICERCA CARDIOVASCOLARE, FONDAZIONE SACCO, FORLÌ; UOC CARDIOLOGIA RIMINI, DIPARTIMENTO CARDIOVASCOLARE, AUSL ROMAGNA, RIMINI; UOC RADIOLOGIA RIMINI, DIPARTIMENTO DELLE IMMAGINI, AUSL ROMAGNA, RIMINI; UOC CARDIOLOGIA RAVENNA, DIPARTIMENTO CARDIO
| | - C Dallaserra
- UOC CARDIOLOGIA FORLÌ, DIPARTIMENTO CARDIOVASCOLARE, AUSL ROMAGNA, FORLÌ; UOC RADIOLOGIA FORLÌ, DIPARTIMENTO DELLE IMMAGINI, AUSL ROMAGNA, FORLÌ; UNITÀ DI RICERCA CARDIOVASCOLARE, FONDAZIONE SACCO, FORLÌ; UOC CARDIOLOGIA RIMINI, DIPARTIMENTO CARDIOVASCOLARE, AUSL ROMAGNA, RIMINI; UOC RADIOLOGIA RIMINI, DIPARTIMENTO DELLE IMMAGINI, AUSL ROMAGNA, RIMINI; UOC CARDIOLOGIA RAVENNA, DIPARTIMENTO CARDIO
| | - A Vizzuso
- UOC CARDIOLOGIA FORLÌ, DIPARTIMENTO CARDIOVASCOLARE, AUSL ROMAGNA, FORLÌ; UOC RADIOLOGIA FORLÌ, DIPARTIMENTO DELLE IMMAGINI, AUSL ROMAGNA, FORLÌ; UNITÀ DI RICERCA CARDIOVASCOLARE, FONDAZIONE SACCO, FORLÌ; UOC CARDIOLOGIA RIMINI, DIPARTIMENTO CARDIOVASCOLARE, AUSL ROMAGNA, RIMINI; UOC RADIOLOGIA RIMINI, DIPARTIMENTO DELLE IMMAGINI, AUSL ROMAGNA, RIMINI; UOC CARDIOLOGIA RAVENNA, DIPARTIMENTO CARDIO
| | - F Ottani
- UOC CARDIOLOGIA FORLÌ, DIPARTIMENTO CARDIOVASCOLARE, AUSL ROMAGNA, FORLÌ; UOC RADIOLOGIA FORLÌ, DIPARTIMENTO DELLE IMMAGINI, AUSL ROMAGNA, FORLÌ; UNITÀ DI RICERCA CARDIOVASCOLARE, FONDAZIONE SACCO, FORLÌ; UOC CARDIOLOGIA RIMINI, DIPARTIMENTO CARDIOVASCOLARE, AUSL ROMAGNA, RIMINI; UOC RADIOLOGIA RIMINI, DIPARTIMENTO DELLE IMMAGINI, AUSL ROMAGNA, RIMINI; UOC CARDIOLOGIA RAVENNA, DIPARTIMENTO CARDIO
| | - F Campacci
- UOC CARDIOLOGIA FORLÌ, DIPARTIMENTO CARDIOVASCOLARE, AUSL ROMAGNA, FORLÌ; UOC RADIOLOGIA FORLÌ, DIPARTIMENTO DELLE IMMAGINI, AUSL ROMAGNA, FORLÌ; UNITÀ DI RICERCA CARDIOVASCOLARE, FONDAZIONE SACCO, FORLÌ; UOC CARDIOLOGIA RIMINI, DIPARTIMENTO CARDIOVASCOLARE, AUSL ROMAGNA, RIMINI; UOC RADIOLOGIA RIMINI, DIPARTIMENTO DELLE IMMAGINI, AUSL ROMAGNA, RIMINI; UOC CARDIOLOGIA RAVENNA, DIPARTIMENTO CARDIO
| | - D Grosseto
- UOC CARDIOLOGIA FORLÌ, DIPARTIMENTO CARDIOVASCOLARE, AUSL ROMAGNA, FORLÌ; UOC RADIOLOGIA FORLÌ, DIPARTIMENTO DELLE IMMAGINI, AUSL ROMAGNA, FORLÌ; UNITÀ DI RICERCA CARDIOVASCOLARE, FONDAZIONE SACCO, FORLÌ; UOC CARDIOLOGIA RIMINI, DIPARTIMENTO CARDIOVASCOLARE, AUSL ROMAGNA, RIMINI; UOC RADIOLOGIA RIMINI, DIPARTIMENTO DELLE IMMAGINI, AUSL ROMAGNA, RIMINI; UOC CARDIOLOGIA RAVENNA, DIPARTIMENTO CARDIO
| | - G Di Gianuario
- UOC CARDIOLOGIA FORLÌ, DIPARTIMENTO CARDIOVASCOLARE, AUSL ROMAGNA, FORLÌ; UOC RADIOLOGIA FORLÌ, DIPARTIMENTO DELLE IMMAGINI, AUSL ROMAGNA, FORLÌ; UNITÀ DI RICERCA CARDIOVASCOLARE, FONDAZIONE SACCO, FORLÌ; UOC CARDIOLOGIA RIMINI, DIPARTIMENTO CARDIOVASCOLARE, AUSL ROMAGNA, RIMINI; UOC RADIOLOGIA RIMINI, DIPARTIMENTO DELLE IMMAGINI, AUSL ROMAGNA, RIMINI; UOC CARDIOLOGIA RAVENNA, DIPARTIMENTO CARDIO
| | - G Rinaldi
- UOC CARDIOLOGIA FORLÌ, DIPARTIMENTO CARDIOVASCOLARE, AUSL ROMAGNA, FORLÌ; UOC RADIOLOGIA FORLÌ, DIPARTIMENTO DELLE IMMAGINI, AUSL ROMAGNA, FORLÌ; UNITÀ DI RICERCA CARDIOVASCOLARE, FONDAZIONE SACCO, FORLÌ; UOC CARDIOLOGIA RIMINI, DIPARTIMENTO CARDIOVASCOLARE, AUSL ROMAGNA, RIMINI; UOC RADIOLOGIA RIMINI, DIPARTIMENTO DELLE IMMAGINI, AUSL ROMAGNA, RIMINI; UOC CARDIOLOGIA RAVENNA, DIPARTIMENTO CARDIO
| | - S Vecchio
- UOC CARDIOLOGIA FORLÌ, DIPARTIMENTO CARDIOVASCOLARE, AUSL ROMAGNA, FORLÌ; UOC RADIOLOGIA FORLÌ, DIPARTIMENTO DELLE IMMAGINI, AUSL ROMAGNA, FORLÌ; UNITÀ DI RICERCA CARDIOVASCOLARE, FONDAZIONE SACCO, FORLÌ; UOC CARDIOLOGIA RIMINI, DIPARTIMENTO CARDIOVASCOLARE, AUSL ROMAGNA, RIMINI; UOC RADIOLOGIA RIMINI, DIPARTIMENTO DELLE IMMAGINI, AUSL ROMAGNA, RIMINI; UOC CARDIOLOGIA RAVENNA, DIPARTIMENTO CARDIO
| | - F Mantero
- UOC CARDIOLOGIA FORLÌ, DIPARTIMENTO CARDIOVASCOLARE, AUSL ROMAGNA, FORLÌ; UOC RADIOLOGIA FORLÌ, DIPARTIMENTO DELLE IMMAGINI, AUSL ROMAGNA, FORLÌ; UNITÀ DI RICERCA CARDIOVASCOLARE, FONDAZIONE SACCO, FORLÌ; UOC CARDIOLOGIA RIMINI, DIPARTIMENTO CARDIOVASCOLARE, AUSL ROMAGNA, RIMINI; UOC RADIOLOGIA RIMINI, DIPARTIMENTO DELLE IMMAGINI, AUSL ROMAGNA, RIMINI; UOC CARDIOLOGIA RAVENNA, DIPARTIMENTO CARDIO
| | - L Mellini
- UOC CARDIOLOGIA FORLÌ, DIPARTIMENTO CARDIOVASCOLARE, AUSL ROMAGNA, FORLÌ; UOC RADIOLOGIA FORLÌ, DIPARTIMENTO DELLE IMMAGINI, AUSL ROMAGNA, FORLÌ; UNITÀ DI RICERCA CARDIOVASCOLARE, FONDAZIONE SACCO, FORLÌ; UOC CARDIOLOGIA RIMINI, DIPARTIMENTO CARDIOVASCOLARE, AUSL ROMAGNA, RIMINI; UOC RADIOLOGIA RIMINI, DIPARTIMENTO DELLE IMMAGINI, AUSL ROMAGNA, RIMINI; UOC CARDIOLOGIA RAVENNA, DIPARTIMENTO CARDIO
| | - A Albini
- UOC CARDIOLOGIA FORLÌ, DIPARTIMENTO CARDIOVASCOLARE, AUSL ROMAGNA, FORLÌ; UOC RADIOLOGIA FORLÌ, DIPARTIMENTO DELLE IMMAGINI, AUSL ROMAGNA, FORLÌ; UNITÀ DI RICERCA CARDIOVASCOLARE, FONDAZIONE SACCO, FORLÌ; UOC CARDIOLOGIA RIMINI, DIPARTIMENTO CARDIOVASCOLARE, AUSL ROMAGNA, RIMINI; UOC RADIOLOGIA RIMINI, DIPARTIMENTO DELLE IMMAGINI, AUSL ROMAGNA, RIMINI; UOC CARDIOLOGIA RAVENNA, DIPARTIMENTO CARDIO
| | - M Mughetti
- UOC CARDIOLOGIA FORLÌ, DIPARTIMENTO CARDIOVASCOLARE, AUSL ROMAGNA, FORLÌ; UOC RADIOLOGIA FORLÌ, DIPARTIMENTO DELLE IMMAGINI, AUSL ROMAGNA, FORLÌ; UNITÀ DI RICERCA CARDIOVASCOLARE, FONDAZIONE SACCO, FORLÌ; UOC CARDIOLOGIA RIMINI, DIPARTIMENTO CARDIOVASCOLARE, AUSL ROMAGNA, RIMINI; UOC RADIOLOGIA RIMINI, DIPARTIMENTO DELLE IMMAGINI, AUSL ROMAGNA, RIMINI; UOC CARDIOLOGIA RAVENNA, DIPARTIMENTO CARDIO
| | - G Gardelli
- UOC CARDIOLOGIA FORLÌ, DIPARTIMENTO CARDIOVASCOLARE, AUSL ROMAGNA, FORLÌ; UOC RADIOLOGIA FORLÌ, DIPARTIMENTO DELLE IMMAGINI, AUSL ROMAGNA, FORLÌ; UNITÀ DI RICERCA CARDIOVASCOLARE, FONDAZIONE SACCO, FORLÌ; UOC CARDIOLOGIA RIMINI, DIPARTIMENTO CARDIOVASCOLARE, AUSL ROMAGNA, RIMINI; UOC RADIOLOGIA RIMINI, DIPARTIMENTO DELLE IMMAGINI, AUSL ROMAGNA, RIMINI; UOC CARDIOLOGIA RAVENNA, DIPARTIMENTO CARDIO
| | - S Piciucchi
- UOC CARDIOLOGIA FORLÌ, DIPARTIMENTO CARDIOVASCOLARE, AUSL ROMAGNA, FORLÌ; UOC RADIOLOGIA FORLÌ, DIPARTIMENTO DELLE IMMAGINI, AUSL ROMAGNA, FORLÌ; UNITÀ DI RICERCA CARDIOVASCOLARE, FONDAZIONE SACCO, FORLÌ; UOC CARDIOLOGIA RIMINI, DIPARTIMENTO CARDIOVASCOLARE, AUSL ROMAGNA, RIMINI; UOC RADIOLOGIA RIMINI, DIPARTIMENTO DELLE IMMAGINI, AUSL ROMAGNA, RIMINI; UOC CARDIOLOGIA RAVENNA, DIPARTIMENTO CARDIO
| |
Collapse
|
7
|
Maisano A, Vitolo M, Imberti JF, Bonini N, Albini A, Valenti AC, Sgreccia D, Mantovani M, Malavasi VL, Boriani G. Atrial Fibrillation in the Setting of Acute Pneumonia: Not a Secondary Arrhythmia. Rev Cardiovasc Med 2022. [DOI: 10.31083/j.rcm2305176] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
|
8
|
Shorthose O, Albini A, He L, Maiolino P. Design of a 3D-Printed Soft Robotic Hand With Integrated Distributed Tactile Sensing. IEEE Robot Autom Lett 2022. [DOI: 10.1109/lra.2022.3149037] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
|
9
|
Baldini G, Albini A, Maiolino P, Cannata G. An Atlas for the Inkjet Printing of Large-Area Tactile Sensors. Sensors (Basel) 2022; 22:s22062332. [PMID: 35336503 PMCID: PMC8950613 DOI: 10.3390/s22062332] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 01/10/2022] [Revised: 03/14/2022] [Accepted: 03/15/2022] [Indexed: 12/12/2022]
Abstract
This review aims to discuss the inkjet printing technique as a fabrication method for the development of large-area tactile sensors. The paper focuses on the manufacturing techniques and various system-level sensor design aspects related to the inkjet manufacturing processes. The goal is to assess how printed electronics simplify the fabrication process of tactile sensors with respect to conventional fabrication methods and how these contribute to overcoming the difficulties arising in the development of tactile sensors for real robot applications. To this aim, a comparative analysis among different inkjet printing technologies and processes is performed, including a quantitative analysis of the design parameters, such as the costs, processing times, sensor layout, and general system-level constraints. The goal of the survey is to provide a complete map of the state of the art of inkjet printing, focusing on the most effective topics for the implementation of large-area tactile sensors and a view of the most relevant open problems that should be addressed to improve the effectiveness of these processes.
Collapse
Affiliation(s)
- Giulia Baldini
- Mechatronics and Automatic Control Laboratory, University of Genoa, 16145 Genova, Italy;
- Correspondence: ; Tel.: +39-34-6314-2962
| | | | - Perla Maiolino
- Oxford Robotics Institute, Oxford OX2 6NN, UK; (A.A.); (P.M.)
| | - Giorgio Cannata
- Mechatronics and Automatic Control Laboratory, University of Genoa, 16145 Genova, Italy;
| |
Collapse
|
10
|
Wang SA, Albini A, Maiolino P, Mastrogiovanni F, Cannata G. Fabric Classification Using a Finger-Shaped Tactile Sensor via Robotic Sliding. Front Neurorobot 2022; 16:808222. [PMID: 35280844 PMCID: PMC8904726 DOI: 10.3389/fnbot.2022.808222] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/03/2021] [Accepted: 01/18/2022] [Indexed: 11/13/2022] Open
Abstract
Tactile sensing endows the robots to perceive certain physical properties of the object in contact. Robots with tactile perception can classify textures by touching. Interestingly, textures of fine micro-geometry beyond the nominal resolution of the tactile sensors can also be identified through exploratory robotic movements like sliding. To study the problem of fine texture classification, we design a robotic sliding experiment using a finger-shaped multi-channel capacitive tactile sensor. A feature extraction process is presented to encode the acquired tactile signals (in the form of time series) into a low dimensional (≤7D) feature vector. The feature vector captures the frequency signature of a fabric texture such that fabrics can be classified directly. The experiment includes multiple combinations of sliding parameters, i.e., speed and pressure, to investigate the correlation between sliding parameters and the generated feature space. Results show that changing the contact pressure can greatly affect the significance of the extracted feature vectors. Instead, variation of sliding speed shows no apparent effects. In summary, this paper presents a study of texture classification on fabrics by training a simple k-NN classifier, using only one modality and one type of exploratory motion (sliding). The classification accuracy can reach up to 96%. The analysis of the feature space also implies a potential parametric representation of textures for tactile perception, which could be used for the adaption of motion to reach better classification performance.
Collapse
Affiliation(s)
- Si-ao Wang
- MACLAB, Dipartimento di Informatica, Bioingegneria, Robotica e Ingegneria dei Sistemi, Università degli Studi di Genova, Genoa, Italy
- *Correspondence: Si-ao Wang
| | - Alessandro Albini
- Oxford Robotics Institute, University of Oxford, Oxford, United Kingdom
| | - Perla Maiolino
- Oxford Robotics Institute, University of Oxford, Oxford, United Kingdom
| | - Fulvio Mastrogiovanni
- TheEngineRoom, Dipartimento di Informatica, Bioingegneria, Robotica e Ingegneria dei Sistemi, Università degli Studi di Genova, Genoa, Italy
| | - Giorgio Cannata
- MACLAB, Dipartimento di Informatica, Bioingegneria, Robotica e Ingegneria dei Sistemi, Università degli Studi di Genova, Genoa, Italy
| |
Collapse
|
11
|
Venturelli A, Vitolo M, Albini A, Boriani G. How did COVID-19 affect medical and cardiology journals? A pandemic in literature. J Cardiovasc Med (Hagerstown) 2021; 22:840-847. [PMID: 34482327 PMCID: PMC10100635 DOI: 10.2459/jcm.0000000000001245] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/26/2021] [Revised: 06/28/2021] [Accepted: 08/03/2021] [Indexed: 12/15/2022]
Abstract
BACKGROUND AND AIMS The spreading speed of the COVID-19 pandemic forced the medical community to produce efforts in updating and sharing the evidence about this new disease, trying to preserve the accuracy of the data but at the same time avoiding the potentially harmful delay from discovery to implementation. The aim of our analysis was to assess the impact of the COVID-19 pandemic on medical literature in terms of proportion of COVID-19-related published papers and temporal patterns of publications within a sample of general/internal medicine and cardiology journals. METHODS We searched through PubMed scientific papers published from 1 January 2020 to 31 January 2021 about COVID-19 in ten major medical journals, of which five were in general/internal medicine and five in the cardiology field. We analyzed the proportion of COVID-19-related papers, and we examined temporal trends in the number of published papers. RESULTS Overall, the proportion of COVID-19-related papers was 18.5% (1986/10 756). This proportion was higher among the five selected general/internal medicine journals, compared with cardiology journals (23.8% vs 9.5%). The vast majority of papers were not original articles; in particular, in cardiology journals, there were 28% 'original articles', 17% 'review articles' and 55.1% 'miscellaneous', compared with 20.2%, 5.1% and 74.7% in general/internal medicine journals, respectively. CONCLUSIONS Our analysis highlights the big impact of the COVID-19 pandemic on international scientific literature. General and internal medicine journals were mainly involved, with cardiology journals only at a later time.
Collapse
Affiliation(s)
- Andrea Venturelli
- Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena
| | - Marco Vitolo
- Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena
- Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, Modena, Italy
| | - Alessandro Albini
- Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena
| | - Giuseppe Boriani
- Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena
| |
Collapse
|
12
|
Boriani G, Maisano A, Bonini N, Albini A, Imberti JF, Venturelli A, Camaioni G, Passiatore M, De Mitri G, Nanni G, Girolami D, Siena V, Sgreccia D, Valenti AC, Vitolo M. Implementation of cardiology tele-visits after COVID-19 pandemic: the INFO-COVID survey. Eur Heart J 2021. [DOI: 10.1093/eurheartj/ehab724.3109] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
During the COVID-19 pandemic, implementation of telemedicine has represented a new potential option for outpatient care.
Purpose
The aim of our study was to evaluate digital literacy among cardiology outpatients.
Methods
From March to June 2020 a survey on telehealth among cardiology outpatients was performed. Digital literacy was investigated through six main domains: age; sex; educational level; Internet access; availability of Internet sources; knowledge and use of teleconference software programs.
Results
The study included 1067 patients, median age 79 years, 41.3% females. The majority of the patients (58.0%) had a secondary school degree, but among patients aged ≥75 years old the most represented educational level was primary school or none. Overall, for Internet access, there was a splitting between “never” (42.1%) and “every day” (41.0%), while only 2.7% answered “at least 1/month” and 14.2% “at least 1/week”. In the total population, the most used devices for Internet access were smartphones (59.0%), and WhatsApp represented the most used app (57.3%). Internet users were younger compared to non-Internet users (63 versus 78 years old, respectively) and with a higher educational level. Age and educational level were associated with non-use of Internet (age-per 10-year increase odds ratio [OR] 3.07, 95% confidence interval [CI] 2.54–3.71, secondary school OR 0.18, 95% CI 0.12–0.26, university OR 0.05, 95% CI 0.02–0.10) (Figure 1).
Conclusions
Telemedicine represents an appealing option to implement medical practice, and for its development it is important to address the gaps in patients' digital skills, with age and educational level being key factors in this setting.
Funding Acknowledgement
Type of funding sources: None. Figure 1. Factors associated with Internet non-use
Collapse
Affiliation(s)
- G Boriani
- University of Modena & Reggio Emilia, Modena, Italy
| | - A Maisano
- University of Modena & Reggio Emilia, Modena, Italy
| | - N Bonini
- University of Modena & Reggio Emilia, Modena, Italy
| | - A Albini
- University of Modena & Reggio Emilia, Modena, Italy
| | - J F Imberti
- University of Modena & Reggio Emilia, Modena, Italy
| | - A Venturelli
- University of Modena & Reggio Emilia, Modena, Italy
| | - G Camaioni
- University of Modena & Reggio Emilia, Modena, Italy
| | - M Passiatore
- University of Modena & Reggio Emilia, Modena, Italy
| | - G De Mitri
- University of Modena & Reggio Emilia, Modena, Italy
| | - G Nanni
- University of Modena & Reggio Emilia, Modena, Italy
| | - D Girolami
- University of Modena & Reggio Emilia, Modena, Italy
| | - V Siena
- University of Modena & Reggio Emilia, Modena, Italy
| | - D Sgreccia
- University of Modena & Reggio Emilia, Modena, Italy
| | - A C Valenti
- University of Modena & Reggio Emilia, Modena, Italy
| | - M Vitolo
- University of Modena & Reggio Emilia, Modena, Italy
| |
Collapse
|
13
|
Vitolo M, Imberti JF, Maisano A, Albini A, Bonini N, Valenti AC, Malavasi VL, Proietti M, Healey JS, Lip GY, Boriani G. Device-detected atrial high rate episodes and the risk of stroke/thrombo-embolism and atrial fibrillation incidence: a systematic review and meta-analysis. Eur J Intern Med 2021; 92:100-106. [PMID: 34154879 DOI: 10.1016/j.ejim.2021.05.038] [Citation(s) in RCA: 28] [Impact Index Per Article: 9.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/08/2021] [Revised: 05/18/2021] [Accepted: 05/26/2021] [Indexed: 01/09/2023]
Abstract
BACKGROUND Atrial High Rate Episodes (AHRE) are asymptomatic atrial tachy-arrhythmias detected through continuous monitoring with a cardiac implantable electronic device. The risks of stroke/Thromboembolic (TE) events and incident clinical Atrial Fibrillation (AF) associated with AHRE varies markedly. OBJECTIVES To assess the relationship between AHRE and TE events, and between AHRE and incident clinical AF. METHODS This systematic review and meta-analysis was conducted following the PRISMA recommendations. PubMed, Scopus, and Google Scholar were searched from inception to 18/02/2021 for studies reporting TE events and incident clinical AF in patients with AHRE, as compared with patients without. RESULTS Ten out of 8081 records fulfilled the inclusion criteria, for a total of 37 266 patients. Seven out of ten studies excluded patients with prior history of clinical AF (4961 patients), embracing the most recent definition of AHRE. The risk ratio (RR) for TE events in AHRE patients was 2.13 (95% CI: 1.53-2.95, I2: 0%). The incidence of clinical AF was reported in four studies excluding patients with a history of clinical AF (3574 patients). The RR for incident clinical AF was 3.34 (95%CI: 1.89-5.90, I2: 73%). CONCLUSIONS AHRE are significantly associated with systemic thromboembolism and incident clinical AF. Further studies are needed to improve patients' risk stratification and management.
Collapse
Affiliation(s)
- Marco Vitolo
- Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena, Modena, Italy.; Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, Modena, Italy; Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool, United Kingdom
| | - Jacopo F Imberti
- Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena, Modena, Italy.; Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool, United Kingdom
| | - Anna Maisano
- Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena, Modena, Italy
| | - Alessandro Albini
- Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena, Modena, Italy
| | - Niccolò Bonini
- Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena, Modena, Italy
| | - Anna Chiara Valenti
- Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena, Modena, Italy
| | - Vincenzo L Malavasi
- Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena, Modena, Italy
| | - Marco Proietti
- Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool, United Kingdom; Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy; Geriatric Unit, IRCCS Istituti Clinici Scientifici Maugeri, Milan, Italy
| | - Jeff S Healey
- Population Health Research Institute, McMaster University, Hamilton, ON, Canada
| | - Gregory Yh Lip
- Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool, United Kingdom; Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
| | - Giuseppe Boriani
- Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena, Modena, Italy..
| |
Collapse
|
14
|
Mantovani F, Barbieri A, Albini A, Bonini N, Fanti D, Fezzi S, Setti M, Rossi A, Ribichini F, Benfari G. The Common Combination of Aortic Stenosis with Mitral Regurgitation: Diagnostic Insight and Therapeutic Implications in the Modern Era of Advanced Echocardiography and Percutaneous Intervention. J Clin Med 2021; 10:jcm10194364. [PMID: 34640380 PMCID: PMC8509644 DOI: 10.3390/jcm10194364] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/25/2021] [Revised: 09/10/2021] [Accepted: 09/20/2021] [Indexed: 11/16/2022] Open
Abstract
The combination of aortic stenosis (AS) and mitral regurgitation (MR) is common in patients with degenerative valvular disease. It is characterized by having complex pathophysiology, leading to potential diagnostic pitfalls. Evidence is scarce in the literature to direct the diagnostic framework and treatment of patients with this particular combination of multiple valvular diseases. In this complex scenario, the appropriate use of advanced echocardiography and multimodality imaging methods plays a central role. Transcatheter mitral valve replacement or repair and transcatheter aortic valve replacement widen the surgical options for valve diseases. Therefore, there is an increasing need to reconsider the function, timing, and mode intervention for patients with a combination of AS with MR towards more personalized treatment.
Collapse
Affiliation(s)
- Francesca Mantovani
- Division of Cardiology, Azienda USL–IRCCS di Reggio Emilia, 42122 Reggio Emilia, Italy;
| | - Andrea Barbieri
- Division of Cardiology, Department of Diagnostics, Clinical and Public Health Medicine, Policlinico University Hospital of Modena, University of Modena and Reggio Emilia, 41121 Modena, Italy; (A.B.); (A.A.); (N.B.)
| | - Alessandro Albini
- Division of Cardiology, Department of Diagnostics, Clinical and Public Health Medicine, Policlinico University Hospital of Modena, University of Modena and Reggio Emilia, 41121 Modena, Italy; (A.B.); (A.A.); (N.B.)
| | - Niccolò Bonini
- Division of Cardiology, Department of Diagnostics, Clinical and Public Health Medicine, Policlinico University Hospital of Modena, University of Modena and Reggio Emilia, 41121 Modena, Italy; (A.B.); (A.A.); (N.B.)
| | - Diego Fanti
- Section of Cardiology, University of Verona, 37129 Verona, Italy; (D.F.); (S.F.); (M.S.); (A.R.); (F.R.)
| | - Simone Fezzi
- Section of Cardiology, University of Verona, 37129 Verona, Italy; (D.F.); (S.F.); (M.S.); (A.R.); (F.R.)
| | - Martina Setti
- Section of Cardiology, University of Verona, 37129 Verona, Italy; (D.F.); (S.F.); (M.S.); (A.R.); (F.R.)
| | - Andrea Rossi
- Section of Cardiology, University of Verona, 37129 Verona, Italy; (D.F.); (S.F.); (M.S.); (A.R.); (F.R.)
| | - Flavio Ribichini
- Section of Cardiology, University of Verona, 37129 Verona, Italy; (D.F.); (S.F.); (M.S.); (A.R.); (F.R.)
| | - Giovanni Benfari
- Section of Cardiology, University of Verona, 37129 Verona, Italy; (D.F.); (S.F.); (M.S.); (A.R.); (F.R.)
- Correspondence: ; Tel.: +39-045-8122320
| |
Collapse
|
15
|
Albini A, Peres AM, Almeida MDLD. Contributions of the Simplified Competency Management Model to a Municipal Health Secretariat. Rev Lat Am Enfermagem 2021; 29:e3429. [PMID: 34231788 PMCID: PMC8253350 DOI: 10.1590/1518-8345.3385.3429] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/18/2019] [Accepted: 09/12/2020] [Indexed: 11/22/2022] Open
Abstract
Objective: to present the contributions of the Simplified Competency Management Model
in a municipal health secretariat. Method: research of integrated mixed methods of exploratory-descriptive type. The
model was applied in a southern Brazilian city, in the following stages:
documentary, questionnaire, mapping of gaps and educational proposal. Results: in the first stage, after documentary research, a total of 14 general core
competences were described and a questionnaire with specific core
competences was chosen, with confirmation of correlation among them; in the
second stage, the importance and expression competence at work degrees were
obtained, after the questionnaires were filled out by 74 municipal public
health managers; in the third one, a formula was adopted for the training
priority degree and its classification; the fourth stage presented an
educational proposal for the development of one of the competences with the
highest priority degree. Conclusion: the model brings contributions by describing general core competences, after
documentary research; carrying out the correlation between a questionnaire,
containing specific core competences with the general ones; by mapping gaps;
and by the proposal of learning trails for the development of
competences.
Collapse
Affiliation(s)
- Alessandro Albini
- Prefeitura Municipal de São José dos Pinhais, Secretaria Municipal de Saúde, São José dos Pinhais, PR, Brazil
| | | | | |
Collapse
|
16
|
Albini A, Grella F, Maiolino P, Cannata G. Exploiting Distributed Tactile Sensors to Drive a Robot Arm Through Obstacles. IEEE Robot Autom Lett 2021. [DOI: 10.1109/lra.2021.3068110] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
|
17
|
Malagoli A, Albini A, Mandoli GE, Baggiano A, Vinco G, Bandera F, D'Andrea A, Esposito R, D'Ascenzi F, Sorrentino R, Santoro C, Benfari G, Contorni F, Cameli M. Multimodality imaging of the ischemic right ventricle: an overview and proposal of a diagnostic algorithm. Int J Cardiovasc Imaging 2021; 37:3343-3354. [PMID: 34114150 DOI: 10.1007/s10554-021-02309-w] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/18/2021] [Accepted: 06/04/2021] [Indexed: 10/21/2022]
Abstract
Right ventricular (RV) involvement is frequently detected in patients presenting with acute left ventricular myocardial infarction. The ischemic right ventricle carries a dismal outcome by predisposing the heart to arrhythmic events and mechanical or hemodynamic complications. A comprehensive RV evaluation by multimodality imaging could guide clinical practice but has always been a conundrum for the imagers. Two-dimensional echocardiography is the best first-line tool due to its availability of bedside capabilities. More advanced imaging techniques provide a more comprehensive evaluation of the complex RV geometry but are mostly reserved for the post-acute setting. Three-dimensional echocardiography has improved the evaluation of RV volumes and function. The recent application of speckle-tracking echocardiography to the right ventricle appears promising, allowing the earlier detection of subtle RV dysfunction. Cardiac magnetic resonance imaging is considered the gold standard for the RV assessment. Cardiac multidetector computed tomography could be a reliable alternative. The aim of this review is to focus on the growing importance of multimodality imaging of the ischemic right ventricle and to propose a diagnostic algorithm, in order to reach a comprehensive assessment of this too frequently neglected chamber.
Collapse
Affiliation(s)
- A Malagoli
- Division of Cardiology, Nephro-Cardiovascular Department, Baggiovara Hospital, University of Modena and Reggio Emilia, Modena, Italy.
| | - A Albini
- Division of Cardiology, Nephro-Cardiovascular Department, Policlinico University Hospital of Modena, University of Modena and Reggio Emilia, Modena, Italy
| | - G E Mandoli
- Department of Cardiovascular Diseases, University of Siena, Siena, Italy
| | - A Baggiano
- Cardiovascular Imaging Department, Centro Cardiologico Monzino IRCCS, Milan, Italy.,Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy
| | - G Vinco
- Department of Medicine, University of Verona, Verona, Italy
| | - F Bandera
- Cardiology University Department, Heart Failure Unit, Department of Biomedical Sciences for Health, IRCCS, Policlinico San Donato, San Donato Milanese, Milan, Italy.,Department of Biomedical Sciences for Health, University of Milano, Milan, Italy
| | - A D'Andrea
- Division of Cardiology, Umberto I' Hospital Nocera Inferiore (Salerno), Luigi Vanvitelli University, Caserta, Italy
| | - R Esposito
- Department of Advanced Biomedical Science, Federico II University Hospital Naples, Naples, Italy
| | - F D'Ascenzi
- Department of Cardiovascular Diseases, University of Siena, Siena, Italy
| | - R Sorrentino
- Department of Advanced Biomedical Science, Federico II University Hospital Naples, Naples, Italy
| | - C Santoro
- Department of Advanced Biomedical Science, Federico II University Hospital Naples, Naples, Italy
| | - G Benfari
- Division of Cardiology, Department of Medicine, University of Verona, Verona, Italy
| | - F Contorni
- Department of Cardiovascular Diseases, University of Siena, Siena, Italy
| | - M Cameli
- Department of Cardiovascular Diseases, University of Siena, Siena, Italy
| | | |
Collapse
|
18
|
Barbieri A, Albini A, Maisano A, De Mitri G, Camaioni G, Bonini N, Mantovani F, Boriani G. Clinical Value of Complex Echocardiographic Left Ventricular Hypertrophy Classification Based on Concentricity, Mass, and Volume Quantification. Front Cardiovasc Med 2021; 8:667984. [PMID: 33987213 PMCID: PMC8110723 DOI: 10.3389/fcvm.2021.667984] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/15/2021] [Accepted: 03/24/2021] [Indexed: 12/28/2022] Open
Abstract
Echocardiography is the most validated, non-invasive and used approach to assess left ventricular hypertrophy (LVH). Alternative methods, specifically magnetic resonance imaging, provide high cost and practical challenges in large scale clinical application. To include a wide range of physiological and pathological conditions, LVH should be considered in conjunction with the LV remodeling assessment. The universally known 2-group classification of LVH only considers the estimation of LV mass and relative wall thickness (RWT) to be classifying variables. However, knowledge of the 2-group patterns provides particularly limited incremental prognostic information beyond LVH. Conversely, LV enlargement conveys independent prognostic utility beyond LV mass for incident heart failure. Therefore, a 4-group LVH subdivision based on LV mass, LV volume, and RWT has been recently suggested. This novel LVH classification is characterized by distinct differences in cardiac function, allowing clinicians to distinguish between different LV hemodynamic stress adaptations in various cardiovascular diseases. The new 4-group LVH classification has the advantage of optimizing the LVH diagnostic approach and the potential to improve the identification of maladaptive responses that warrant targeted therapy. In this review, we summarize the current knowledge on clinical value of this refinement of the LVH classification, emphasizing the role of echocardiography in applying contemporary proposed indexation methods and partition values.
Collapse
Affiliation(s)
- Andrea Barbieri
- Division of Cardiology, Department of Diagnostics, Clinical and Public Health Medicine, Policlinico University Hospital of Modena, University of Modena and Reggio Emilia, Modena, Italy
| | - Alessandro Albini
- Division of Cardiology, Department of Diagnostics, Clinical and Public Health Medicine, Policlinico University Hospital of Modena, University of Modena and Reggio Emilia, Modena, Italy
| | - Anna Maisano
- Division of Cardiology, Department of Diagnostics, Clinical and Public Health Medicine, Policlinico University Hospital of Modena, University of Modena and Reggio Emilia, Modena, Italy
| | - Gerardo De Mitri
- Division of Cardiology, Department of Diagnostics, Clinical and Public Health Medicine, Policlinico University Hospital of Modena, University of Modena and Reggio Emilia, Modena, Italy
| | - Giovanni Camaioni
- Division of Cardiology, Department of Diagnostics, Clinical and Public Health Medicine, Policlinico University Hospital of Modena, University of Modena and Reggio Emilia, Modena, Italy
| | - Niccolò Bonini
- Division of Cardiology, Department of Diagnostics, Clinical and Public Health Medicine, Policlinico University Hospital of Modena, University of Modena and Reggio Emilia, Modena, Italy
| | | | - Giuseppe Boriani
- Division of Cardiology, Department of Diagnostics, Clinical and Public Health Medicine, Policlinico University Hospital of Modena, University of Modena and Reggio Emilia, Modena, Italy
| |
Collapse
|
19
|
Albini A, Malavasi VL, Vitolo M, Imberti JF, Marietta M, Lip GYH, Boriani G. Long-term outcomes of postoperative atrial fibrillation following non cardiac surgery: A systematic review and metanalysis. Eur J Intern Med 2021; 85:27-33. [PMID: 33402281 DOI: 10.1016/j.ejim.2020.12.018] [Citation(s) in RCA: 17] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/10/2020] [Revised: 12/08/2020] [Accepted: 12/24/2020] [Indexed: 12/31/2022]
Abstract
BACKGROUND New-onset atrial fibrillation (AF) in non-cardiac postoperative setting is common and is associated with a high risk of in-hospital mortality and morbidity. The long-term risks of stroke, mortality and AF recurrence rate in patients with postoperative AF (POAF) are unclear. METHODS We performed a systematic literature review in electronic databases from inception to March 5th, 2020 of studies reporting the incidence of stroke, mortality and AF recurrence in patients with POAF. We confined our analysis to studies with a cohort of at least 150 patients with POAF and with a median follow-up of 12 months as a minimum. Odds Ratios (OR) were pooled using a random-effects model. RESULTS Qualitative analysis included 8 studies (7 observational cohort studies and 1 randomized controlled trial) enrolling 3,718,587 patients. Six studies underwent metanalysis comprising 17,684 postoperative patients with POAF and 2,169,248 postoperative patients without POAF. The development of POAF conferred a four-fold increased risk of stroke in the long-term [OR 4.05; 95% confidence interval (CI) 2.91-5.62]. Mortality in the two studies reporting long-term data was higher in patients with POAF compared to those without POAF (OR 3.59; CI 95% 2.84-4.53). Data about recurrence were too heterogeneous to undergo metanalysis. CONCLUSIONS POAF is associated with a greater risk of stroke and mortality over the long-term period. Studies focusing on AF recurrence are needed to address the perception of POAF as a benign transient entity. The increased mortality risk following POAF should encourage systematic detection and prevention of this arrhythmia.
Collapse
Affiliation(s)
- Alessandro Albini
- Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena, Modena, Italy
| | - Vincenzo Livio Malavasi
- Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena, Modena, Italy
| | - Marco Vitolo
- Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena, Modena, Italy; Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool, United Kingdom
| | - Jacopo Francesco Imberti
- Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena, Modena, Italy
| | - Marco Marietta
- Department of Oncology and Haematology, University Hospital, Modena, Italy
| | - Gregory Y H Lip
- Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool, United Kingdom; Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
| | - Giuseppe Boriani
- Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena, Modena, Italy.
| |
Collapse
|
20
|
Malagoli A, Albini A, Baldini L, Grassi L, Tondi S. Imaging a unicuspid aortic valve with transillumination. Echocardiography 2021; 38:504-505. [PMID: 33611817 DOI: 10.1111/echo.15003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/22/2020] [Revised: 01/22/2021] [Accepted: 02/01/2021] [Indexed: 11/28/2022] Open
Abstract
Unicuspid aortic valve (UAV) is a rare congenital malformation which portends an augmented risk of early valve degeneration. Timely detection of this cardiac valvular anomaly is crucial because a strict follow-up is warranted. Currently, the best morphological information is provided by two-dimensional echocardiography; however, its diagnostic performance has been found to be suboptimal by some anatomical features, making it tough to distinguish between UAV and bicuspid aortic valve. Transillumination is a photo-realism technique that employs the use of a virtual light source that simulates the interaction of light on 3-dimensional surfaces, improving the visualization of morphological characteristics. Our report highlights the incremental value of photo-realistic rendering and lighting source technology to better define the aortic valve morphology.
Collapse
Affiliation(s)
- Alessandro Malagoli
- Division of Cardiology, Nephro-Cardiovascular Department, Baggiovara Hospital, University of Modena and Reggio Emilia, Modena, Italy
| | - Alessandro Albini
- Division of Cardiology, Nephro-Cardiovascular Department, Policlinic University Hospital of Modena, University of Modena and Reggio Emilia, Modena, Italy
| | - Luca Baldini
- Radiology Unit, Baggiovara Hospital, University of Modena and Reggio Emilia, Modena, Italy
| | - Laura Grassi
- Division of Cardiology, Nephro-Cardiovascular Department, Baggiovara Hospital, University of Modena and Reggio Emilia, Modena, Italy
| | - Stefano Tondi
- Division of Cardiology, Nephro-Cardiovascular Department, Baggiovara Hospital, University of Modena and Reggio Emilia, Modena, Italy
| |
Collapse
|
21
|
|
22
|
Boriani G, Bonini N, Albini A, Venturelli A, Imberti JF, Vitolo M. Cardioversion of recent-onset atrial fibrillation: current evidence, practical considerations, and controversies in a complex clinical scenario. Kardiol Pol 2020; 78:1088-1098. [PMID: 33021354 DOI: 10.33963/kp.15638] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
Atrial fibrillation (AF) represents the most common arrhythmia and is associated with increased morbidity and mortality generating high social costs. Due to its high prevalence, AF is usually managed not only by cardiologists but also by general practitioners or clinicians in emergency departments. The conventional classification of AF includes "recent‑onset AF" defined as an arrhythmia episode shorter than 48 hours. In patients with a definite duration of AF of less than 24 hours and a very low-risk profile (CHA2DS2VASc of 0 in men and 1 in women), the thromboembolic risk seems to be low, and the standard 4‑week anticoagulation therapy is now regarded as optional treatment. Cardioversion (electrical or pharmacological) in recent‑onset AF represents a valid rhythm control strategy. Electrical cardioversion is usually reserved for hemodynamically unstable patients and performed with biphasic waveform shocks. On the other hand, pharmacological cardioversion is preferred in hemodynamically stable patients. Several antiarrhythmic drugs have been studied so far, but some questions still remain unresolved mainly due to lack of randomized clinical trials and prospective studies. The current guidelines do not uniformly agree on which drug to use for pharmacological cardioversion, and drug preference varies widely in clinical practice. The aim of this narrative review is to sum up and critically evaluate novel evidence regarding recent‑onset AF as well as to provide some practical considerations particularly focused on rhythm control with pharmacological cardioversion.
Collapse
|
23
|
Boriani G, Imberti JF, Bonini N, Albini A, Autieri A, Vitolo M. [Atrial high-rate episodes: clinical significance, prognostic impact and clinical management]. G Ital Cardiol (Rome) 2020; 21:779-789. [PMID: 32968315 DOI: 10.1714/3431.34204] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/11/2023]
Abstract
The rapid increase in cardiac implantable electronic device (CIED) implants and their ability to monitor atrial activity significantly contributed to a parallel increase in the occasional detection of atrial tachyarrhythmias, termed as atrial high-rate episodes (AHREs). These episodes of atrial tachyarrhythmia are usually asymptomatic and they are often diagnosed incidentally during the regular follow-up of patients with CIEDs or during the diagnostic work-up for patients affected by cryptogenic stroke. Over the past 20 years, numerous studies attempted to demonstrate the clinical significance and prognostic impact of these episodes, but their clinical management remains unclear. However, AHREs are not only significantly associated with a greater risk of developing clinical atrial fibrillation over time, but are also associated with an increased risk of cerebral and/or systemic thromboembolic events. Therefore, if deemed favorable, the use of oral anticoagulant therapy may be reasonable. The purpose of this review is to perform a state of the art analysis focusing on the clinical management of AHREs, their prognostic impact, the risks and benefits of anticoagulation and the critical issues that have emerged in the last years of studies.
Collapse
Affiliation(s)
- Giuseppe Boriani
- S.C. Cardiologia, Dipartimento di Scienze Biomediche, Metaboliche e Neuroscienze, Università degli Studi di Modena e Reggio Emilia, Azienda Ospedaliero-Universitaria Policlinico di Modena, Modena
| | - Jacopo Francesco Imberti
- S.C. Cardiologia, Dipartimento di Scienze Biomediche, Metaboliche e Neuroscienze, Università degli Studi di Modena e Reggio Emilia, Azienda Ospedaliero-Universitaria Policlinico di Modena, Modena
| | - Niccolò Bonini
- S.C. Cardiologia, Dipartimento di Scienze Biomediche, Metaboliche e Neuroscienze, Università degli Studi di Modena e Reggio Emilia, Azienda Ospedaliero-Universitaria Policlinico di Modena, Modena
| | - Alessandro Albini
- S.C. Cardiologia, Dipartimento di Scienze Biomediche, Metaboliche e Neuroscienze, Università degli Studi di Modena e Reggio Emilia, Azienda Ospedaliero-Universitaria Policlinico di Modena, Modena
| | - Adriano Autieri
- S.C. Cardiologia, Dipartimento di Scienze Biomediche, Metaboliche e Neuroscienze, Università degli Studi di Modena e Reggio Emilia, Azienda Ospedaliero-Universitaria Policlinico di Modena, Modena
| | - Marco Vitolo
- S.C. Cardiologia, Dipartimento di Scienze Biomediche, Metaboliche e Neuroscienze, Università degli Studi di Modena e Reggio Emilia, Azienda Ospedaliero-Universitaria Policlinico di Modena, Modena
| |
Collapse
|
24
|
Denegri A, Albini A, Barbieri A, Boriani G. A giant right coronary artero-venous fistula revealed by an integrated multimodality imaging approach. Intern Emerg Med 2020; 15:1331-1332. [PMID: 32274648 DOI: 10.1007/s11739-020-02324-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/05/2020] [Accepted: 03/24/2020] [Indexed: 11/24/2022]
Affiliation(s)
- Andrea Denegri
- Cardiology Division, Policlinico di Modena, Azienda Ospedaliero-Universitaria di Modena, Largo del Pozzo, 71, 41125, Modena, Italy.
| | - Alessandro Albini
- Cardiology Division, Policlinico di Modena, Azienda Ospedaliero-Universitaria di Modena, Largo del Pozzo, 71, 41125, Modena, Italy
| | - Andrea Barbieri
- Cardiology Division, Policlinico di Modena, Azienda Ospedaliero-Universitaria di Modena, Largo del Pozzo, 71, 41125, Modena, Italy
| | - Giuseppe Boriani
- Cardiology Division, Policlinico di Modena, Azienda Ospedaliero-Universitaria di Modena, Largo del Pozzo, 71, 41125, Modena, Italy
| |
Collapse
|
25
|
Abstract
This article deals with the problem of the recognition of human hand touch by a robot equipped with large area tactile sensors covering its body. This problem is relevant in the domain of physical human–robot interaction for discriminating between human and non-human contacts and to trigger and to drive cooperative tasks or robot motions, or to ensure a safe interaction. The underlying assumption used in this article is that voluntary physical interaction tasks involve hand touch over the robot body, and therefore the capability to recognize hand contacts is a key element to discriminate a purposive human touch from other types of interaction. The proposed approach is based on a geometric transformation of the tactile data, formed by pressure measurements associated to a non-uniform cloud of 3D points ( taxels) spread over a non-linear manifold corresponding to the robot body, into tactile images representing the contact pressure distribution in two dimensions. Tactile images can be processed using deep learning algorithms to recognize human hands and to compute the pressure distribution applied by the various hand segments: palm and single fingers. Experimental results, performed on a real robot covered with robot skin, show the effectiveness of the proposed methodology. Moreover, to evaluate its robustness, various types of failures have been simulated. A further analysis concerning the transferability of the system has been performed, considering contacts occurring on a different sensorized robot part.
Collapse
Affiliation(s)
- Alessandro Albini
- Department of Informatics, Bioengineering, Robotics and Systems Engineering (DIBRIS), University of Genoa, Genoa, Italy
| | - Giorgio Cannata
- Department of Informatics, Bioengineering, Robotics and Systems Engineering (DIBRIS), University of Genoa, Genoa, Italy
| |
Collapse
|
26
|
Cantaluppi V, Deregibus M, Biancone L, Deambrosis I, Bussolati B, Albini A, Camussi G. The Expression of CD154 by Kaposi's Sarcoma Cells Mediates the Anti-Apoptotic and Migratory Effects of HIV-1-Tat Protein. Int J Immunopathol Pharmacol 2018. [DOI: 10.1177/205873920601900108] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
Kaposi's sarcoma (KS) is a malignancy associated to conditions of immune system impairment such as HIV-1 infection and post-transplantation therapy. Here we report that HIV-1-Tat protein, at concentrations well below those detected in AIDS patients, up-regulates the expression of both CD40 and CD154 on KS cells. This occurred also in the presence of vincristine, that at doses shown to induce apoptosis decreased the expression of both CD40 and CD154 on KS cells. The treatment with a soluble CD40-muIg fusion protein (CD40 fp) that prevents the binding of CD154 with cell surface CD40, as well as the transfection with a vector for soluble CD40 (KS sCD40), decreased the anti-apoptotic effect of Tat. Moreover, Tat-induced motility of KS cells was inhibited by soluble CD40 fp. Tat also enhanced the expression of intracellular proteins known to transduce signals triggered by CD40 engagement, in particular TRAF-3. Tat as well as soluble CD154 (sCD154) prevented vincristine-induced reduction of TRAF-3 in KS cells transfected with a vector for neomycin resistance (KS psv-neo), but not in KS sCD40. Immunoprecipitation studies showed that Tat induced CD40 / TRAF-3 association and that this binding was abrogated upon the incubation with the soluble CD40 fp. These data suggest that Tat activates the CD40-CD154 pathway by enhancing the membrane expression of CD40 and in particular of CD154, and by activating the TRAF-3-dependent signaling pathway of CD40. These findings indicate that the CD40-CD154 pathway mediates the anti-apoptotic and migratory effects of HIV-1-Tat, suggesting the potential therapeutic benefits of blocking CD40 activation in HIV-1-associated KS.
Collapse
Affiliation(s)
- V. Cantaluppi
- Renal and Vascular Immunopathology Laboratory, Research Center for Experimental Medicine (CeRMS), Department of Internal Medicine, University of Torino, Italy
| | - M.C. Deregibus
- Renal and Vascular Immunopathology Laboratory, Research Center for Experimental Medicine (CeRMS), Department of Internal Medicine, University of Torino, Italy
| | - L. Biancone
- Renal and Vascular Immunopathology Laboratory, Research Center for Experimental Medicine (CeRMS), Department of Internal Medicine, University of Torino, Italy
| | - I. Deambrosis
- Renal and Vascular Immunopathology Laboratory, Research Center for Experimental Medicine (CeRMS), Department of Internal Medicine, University of Torino, Italy
| | - B. Bussolati
- Renal and Vascular Immunopathology Laboratory, Research Center for Experimental Medicine (CeRMS), Department of Internal Medicine, University of Torino, Italy
| | - A. Albini
- Molecular Oncology Laboratory, National Institute for Cancer Research, Genova, Italy
| | - G. Camussi
- Renal and Vascular Immunopathology Laboratory, Research Center for Experimental Medicine (CeRMS), Department of Internal Medicine, University of Torino, Italy
| |
Collapse
|
27
|
Rinaldi A, Dardi F, Albini A, Gotti E, Monti E, Palazzini M, Zuffa E, Guarino D, Pasca F, De Lorenzis A, Orzalkiewicz M, Manes A, Galie' N. P6341Haemodynamic and exercise effects of different types of initial oral combination therapy in pulmonary arterial hypertension. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy566.p6341] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- A Rinaldi
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| | - F Dardi
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| | - A Albini
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| | - E Gotti
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| | - E Monti
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| | - M Palazzini
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| | - E Zuffa
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| | - D Guarino
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| | - F Pasca
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| | - A De Lorenzis
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| | - M Orzalkiewicz
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| | - A Manes
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| | - N Galie'
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| |
Collapse
|
28
|
Monti E, Rinaldi A, Dardi F, Palazzini M, Gotti E, Albini A, Zuffa E, Guarino D, Pasca F, De Lorenzis A, Cassani A, Orzalkiewicz M, Manes A, Galie' N. P3559Effect of pulmonary arterial hypertension specific therapy in the four clinical subgroups of patients with pulmonary arterial hypertension associated with congenital heart disease. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy563.p3559] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- E Monti
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| | - A Rinaldi
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| | - F Dardi
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| | - M Palazzini
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| | - E Gotti
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| | - A Albini
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| | - E Zuffa
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| | - D Guarino
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| | - F Pasca
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| | - A De Lorenzis
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| | - A Cassani
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| | - M Orzalkiewicz
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| | - A Manes
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| | - N Galie'
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| |
Collapse
|
29
|
Gotti E, Saia F, Palazzini M, Dardi F, Rinaldi A, Monti E, Albini A, Zuffa E, Guarino D, Pasca F, De Lorenzis A, Orzalkiewicz M, Manes A, Marzocchi A, Galie' N. P6343Experience of two years of balloon pulmonary angioplasty in a single center: safety and short term results. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy566.p6343] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- E Gotti
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| | - F Saia
- Bologna University Hospital, Cardiology, Bologna, Italy
| | - M Palazzini
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| | - F Dardi
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| | - A Rinaldi
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| | - E Monti
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| | - A Albini
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| | - E Zuffa
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| | - D Guarino
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| | - F Pasca
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| | - A De Lorenzis
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| | - M Orzalkiewicz
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| | - A Manes
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| | - A Marzocchi
- Bologna University Hospital, Cardiology, Bologna, Italy
| | - N Galie'
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| |
Collapse
|
30
|
Dardi F, Palazzini M, Gotti E, Rinaldi A, Albini A, Monti E, Zuffa E, Guarino D, Pasca F, De Lorenzis A, Orzalkiewicz M, Manes A, Galie' N. P4538Simplified table for risk stratification in patients with different types of pulmonary arterial hypertension. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy563.p4538] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- F Dardi
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| | - M Palazzini
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| | - E Gotti
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| | - A Rinaldi
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| | - A Albini
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| | - E Monti
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| | - E Zuffa
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| | - D Guarino
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| | - F Pasca
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| | - A De Lorenzis
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| | - M Orzalkiewicz
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| | - A Manes
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| | - N Galie'
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| |
Collapse
|
31
|
Dardi F, Tanese N, Caravita S, Rinaldi A, Dewachter C, Gotti E, Nguyen T, Monti E, Albini A, Palazzini M, Manes A, Vachiery JL, Galie' N. P4542A new score to differentiate idiopathic pulmonary arterial hypertension from pulmonary hypertension due to heart failure with preserved ejection fraction. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy563.p4542] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- F Dardi
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| | - N Tanese
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| | - S Caravita
- San Luca Hospital of Milan, Cardiology, IRCCS, Auxological Institute, Milan, Italy
| | - A Rinaldi
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| | - C Dewachter
- Erasme Hospital (ULB), Cardiology, Pulmonary Hypertension and Heart Failure Clinic, Brussels, Belgium
| | - E Gotti
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| | - T Nguyen
- Erasme Hospital (ULB), Cardiology, Pulmonary Hypertension and Heart Failure Clinic, Brussels, Belgium
| | - E Monti
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| | - A Albini
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| | - M Palazzini
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| | - A Manes
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| | - J L Vachiery
- Erasme Hospital (ULB), Cardiology, Pulmonary Hypertension and Heart Failure Clinic, Brussels, Belgium
| | - N Galie'
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| |
Collapse
|
32
|
De Lorenzis A, Dardi F, Monti E, Gotti E, Palazzini M, Rinaldi A, Albini A, Zuffa E, Guarino D, Pasca F, Orzalkiewicz M, Manes A, Galie' N. P1629Role of cardiac magnetic resonance in stratifying the prognosis of patients with pulmonary arterial hypertension. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy565.p1629] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- A De Lorenzis
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| | - F Dardi
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| | - E Monti
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| | - E Gotti
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| | - M Palazzini
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| | - A Rinaldi
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| | - A Albini
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| | - E Zuffa
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| | - D Guarino
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| | - F Pasca
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| | - M Orzalkiewicz
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| | - A Manes
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| | - N Galie'
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| |
Collapse
|
33
|
Zuffa E, Dardi F, Palazzini M, Gotti E, Rinaldi A, Albini A, Monti E, Guarino D, Pasca F, De Lorenzis A, Orzalkiewicz M, Manes A, Galie' N. 3018Comparison between paediatric and adult patients with pulmonary arterial hypertension. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy563.3018] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- E Zuffa
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| | - F Dardi
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| | - M Palazzini
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| | - E Gotti
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| | - A Rinaldi
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| | - A Albini
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| | - E Monti
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| | - D Guarino
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| | - F Pasca
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| | - A De Lorenzis
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| | - M Orzalkiewicz
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| | - A Manes
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| | - N Galie'
- University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
| |
Collapse
|
34
|
Allavena G, Melchiori A, Carlone S, Di Renzo MF, Comoglio P, Parodi S, Santi L, Albini A. High Chemotactic Motility and Growth in Hard Agar of a Variant of RSV-Transformed Fibroblasts are Lost in Late Passages. Tumori 2018; 74:1-6. [PMID: 2832985 DOI: 10.1177/030089168807400101] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
Cloning efficiency in hard agar (0.6%) and high chemotactic migration toward fibroblast conditioned medium have been shown to characterize metastatic tumor cells. We studied growth in 0.6% agar and chemotaxis of two lines of Rous Sarcoma virus-transformed Balb/ c3T3 cells, B77/3T3 (low metastatic) and AA12 (high metastatic), and compared them to their non-transformed counterpart, in order to verify whether these properties were maintained during several subcultivations. Cells were cryopreserved at early passages and thawed for experiments. Both assays were performed on freshly thawed cells (4-6 weeks in culture) and on cells which had been cultured 15-20 weeks after thawing. B77/3T3, which are tumorigenic but low metastatic and which have a very low cloning efficiency in hard agar (0.1-1%), showed a chemotactic response to Balb/c3T3 conditioned medium about two-fold higher than control Balb/c3T3. This response did not change with time in culture. AA12 cells, a genetic unstable variant of B77/3T3 selected for its growth in hard agar (0.6%), had a high cloning efficiency in hard agar and showed a high chemotactic motility (three-fold the controls). High growth in 0.6 % agar and high chemotaxis of AA12 were lost in late passages, where cells behaved as the controls. It seems that besides the already reported variation in anchorage-independent growth, genetically unstable tumor cells can also have important variations in chemotactic motility during subcultivations.
Collapse
Affiliation(s)
- G Allavena
- Istituto Nazionale per la Ricerca sul Cancro, Genova, Italia
| | | | | | | | | | | | | | | |
Collapse
|
35
|
Albini A, Casella R, Santaniello A, Beretta L, Bollati V, Rota F, Cantone L, Dioni L, Lombardi F, Vicenzi M. 30Extracellular vesicles in systemic sclerosis as potential mediator for pulmonary vascular disease. Cardiovasc Res 2018. [DOI: 10.1093/cvr/cvy060.013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- A Albini
- Fondazione IRCCS Cà Granda, Cardiovascular Unit, Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy
| | - R Casella
- Fondazione IRCCS Cà Granda, Cardiovascular Unit, Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy
| | - A Santaniello
- Fondazione IRCCS Cà Granda, Immunological Unit, Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy
| | - L Beretta
- Fondazione IRCCS Cà Granda, Immunological Unit, Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy
| | - V Bollati
- University of Milan, EPIGET Lab, Department of Clinical Sciences and Community, Fondazione IRCCS Ca' Granda, Milan, Italy
| | - F Rota
- University of Milan, EPIGET Lab, Department of Clinical Sciences and Community, Fondazione IRCCS Ca' Granda, Milan, Italy
| | - L Cantone
- University of Milan, EPIGET Lab, Department of Clinical Sciences and Community, Fondazione IRCCS Ca' Granda, Milan, Italy
| | - L Dioni
- University of Milan, EPIGET Lab, Department of Clinical Sciences and Community, Fondazione IRCCS Ca' Granda, Milan, Italy
| | - F Lombardi
- Fondazione IRCCS Cà Granda, Cardiovascular Unit, Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy
| | - M Vicenzi
- Fondazione IRCCS Cà Granda, Cardiovascular Unit, Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy
| |
Collapse
|
36
|
Abstract
The field of antiangiogenesis has shown a remarkably rapid evolution from the discovery at the bench to translation into the clinic. Currently a wide variety of compounds are in clinical trial as inhibitors of angiogenesis, and new compounds are being frequently added. The target cell of most angiogenesis inhibitors is the endothelial cell, with inhibitors that selectively affect a number of endothelial cell functions acquired during angiogenesis, including activation, proliferation, migration, invasion and survival. The endothelial cell may also be targeted by chemotherapeutic agents currently in use. The high doses and intermittent treatment schedules used to fight resistant tumor cells may be altered towards lower doses and chronic administration to obtain selective inhibition of angiogenic factor-stimulated endothelial cells as adjuvant therapy. Finally, gene therapy is a promising route for the delivery of novel protein inhibitors of angiogenesis, and is actively being investigated.
Collapse
Affiliation(s)
- A Albini
- National Institute for Cancer Research, Advanced Biotechnologies Center, Genova, Italy
| | | | | |
Collapse
|
37
|
Morini M, Cai T, Aluigi MG, Noonan DM, Masiello L, De Flora S, D'Agostini F, Albini A, Fassina G. The Role of the Thiol N-Acetylcysteine in the Prevention of Tumor Invasion and Angiogenesis. Int J Biol Markers 2018; 14:268-71. [PMID: 10669958 DOI: 10.1177/172460089901400413] [Citation(s) in RCA: 64] [Impact Index Per Article: 10.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
We have extensively studied the effects of N-acetylcysteine (NAC), a cytoprotective drug that can prevent in vivo carcinogenesis. Here we review our findings NAC completely inhibits gelatinolytic activity of metalloproteases and chemotactic and invasive activities of tumor cells. In addition, NAC reduces the number of lung metastases when malignant murine melanoma cells are injected into nude mice. NAC treatment decreases the weight of primary tumors and produces a dose-related increase in tumor latency. Moreover, oral administration of NAC reduces the formation of spontaneous metastases. In experimental metastasis assays, we have found a synergistic reduction in the number of lung metastases after treatment with doxorubicin (DOX) and NAC in nude mice. In tumorigenicity and spontaneous metastasis assays, the combined administration of DOX and oral NAC again has shown synergistic effects on the frequency and weight of primary tumors and local recurrences and completely prevented the formation of lung metastases. The addition of NAC to endothelial cells strongly reduces their invasive activity in response to angiogenic stimuli. NAC inhibited the degradation and release of radiolabeled type IV collagen by activated endothelial cells, indicating that NAC blocks gelatinase activity. Oral administration of NAC reduces the angiogenic response induced by KS tumor cell products, confirming the ability of NAC to inhibit the invasive activity of endothelial cells in vivo and thereby blocking angiogenesis.
Collapse
Affiliation(s)
- M Morini
- National Institute for Cancer Research, Genova, Italy
| | | | | | | | | | | | | | | | | |
Collapse
|
38
|
Indraccolo S, Minuzzo S, Gola E, Habeler W, Carrozzino F, Noonan D, Albini A, Santi L, Amadori A, Chieco-Bianchi L. Generation of Expression Plasmids for Angiostatin, Endostatin and Timp-2 for Cancer Gene Therapy. Int J Biol Markers 2018; 14:251-6. [PMID: 10669955 DOI: 10.1177/172460089901400410] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Antiangiogenic therapy may represent a promising approach to cancer treatment. Indeed, the efficacy of endogenous angiogenesis inhibitors, including angiostatin, endostatin and TIMPs, has been demonstrated in many types of solid tumors in animal models. In view of the possible problems associated with long-term administration of inhibitors as recombinant proteins, we propose their delivery as nucleic acids through a gene therapy approach. To this end, eukaryotic expression constructs for murine angiostatin and endostatin as well as human TIMP-2 were generated, and characterized in vitro. All constructs carry the relevant cDNAs under the control of the strong HCMV promoter/enhancer, and cleavable leader signals to allow protein secretion. Expression of the angiogenesis inhibitors was detected by in vitro transcription/translation experiments as well as transfection of 293T cells, followed by Western blotting (WB) or radioimmunoprecipitation analysis of both cell lysates and supernatants (SNs). These constructs might be used for in vivo intramuscular delivery of plasmid DNA and as a set of reagents for the development of retroviral as well as adeno-associated viral (AAV) vectors expressing angiogenesis inhibitors.
Collapse
|
39
|
Abstract
Kaposi's Sarcoma (KS) is a pathology which occurs with increased frequency and in a particularly aggressive form in AIDS patients. The HIV-1 Tat protein appears to be an important co-factor in the induction of the extensive neo-vascularization associated with AIDS-KS. Tat acts as a chemoattractant for endothelial cells in vitro, inducing both chemotactic and invasive responses. Several clinical trials have been performed testing the effectiveness of diverse biological agents in therapy of KS, among these the type I interferons. Type I IFNs have diverse biological functions besides their anti-viral activity, including anti-angiogenic properties. We have shown that IFNα and IFNβ are potent inhibitors of both primary and immortalized endothelial cell migration and morphogenesis in vitro as well as neo-angiogenesis induced by HIV-1 Tat in vivo. The inhibitory effect of IFN class I on HIV-Tat associated angiogenesis further supports its use as a therapy for epidemic Kaposi's sarcoma. The use of recombinant IFNs at the levels required to obtain a therapeutic effect are associated with side effects and toxicity, therefore we are now developing a gene therapy approach for constant and local delivery type I IFNs.
Collapse
Affiliation(s)
- C Marchisone
- National Institute for Cancer Research, Advanced Biotechnologies Center, Genova, Italy
| | | | | | | | | |
Collapse
|
40
|
Abstract
Tumor-induced angiogenesis is a key event for neoplastic progression. In vitro assays are important for identification of potential angiogenic agents and rapid sceening for pharmacological inhibitors. The increased interest in this field of study has generated several in vitro assays that recapitulate the steps of endothelial cell activation and differentiation. In this short report we emphasize the utility of Matrigel, a reconstituted basement membrane, to define two different steps in the angiogenic process: invasion in response to growth factors and organization of microvessels into a network with branching morphology on a Matrigel substrate.
Collapse
Affiliation(s)
- R Benelli
- Molecular Oncology Service, Advanced Biotechnologies Center, Genova, Italy
| | | |
Collapse
|
41
|
Albini A, Baci D, Bruno A, Noonan D. A polyphenol-rich extract from olive-mill waste waters targets the IL-6/STAT3 pathway in prostate cancer cell lines. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy047.038] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
42
|
Abstract
Tumors growing within the host form dynamic aberrant tissue that consists of host components, including the stroma, an expanding vasculature and often chronic inflammation, in addition to the tumor cells themselves. These host components can contribute to, rather than limit, tumor expansion, whereas deprivation of vessel formation has the potential to confine tumors in small, clinically silent foci. Therapeutic inhibition of vessel formation could be best suited to preventive strategies aimed at the suppression of angiogenesis in primary tumors in subjects at risk, or of micrometastases after surgical removal of a primary tumor. Our analysis of potential cancer chemopreventive molecules including N-acetylcysteine, green tea flavonoids and 4-hydroxyphenyl-retinamide has identified antiangiogenic activities that could account -at least in part - for the tumor prevention effects observed with these compounds. These drugs appear to target common mechanisms of tumor angiogenesis that may permit identification of critical targets for antiangiogenic therapy and antiangiogenic chemoprevention.
Collapse
Affiliation(s)
- U Pfeffer
- Laboratory of Molecular Oncology, National Cancer Research Institute, Genoa, Italy.
| | | | | | | | | | | |
Collapse
|
43
|
Albini A, Bruno A, Bassani B, Bucci E, Boni L, Dominioni L, Noonan D. Colorectal cancer (CRC) progression and angiogenesis: tumor infiltrating natural killer cells as novel inflammatory orchestrators. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx422.028] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
44
|
Monti E, Dardi F, Gotti E, Palazzini M, Rinaldi A, Albini A, Zuffa E, Guarino D, Pasca F, Tanese N, Manes A, Galie' N. P3525Mortality in pulmonary arterial hypertension trials: a comparison between meta-analyses. Eur Heart J 2017. [DOI: 10.1093/eurheartj/ehx504.p3525] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
45
|
Albini A, Bruno A, Bassani B, D’Urso D, Zanellato S, Aida I, Mortara L, Boni L, Noonan D. Tumour infiltrating (TINK) and Tumour associated (TANK) natural killer cells: novel inflammatory orchestrators in colorectal cancer (CRC) progression and angiogenesis. Eur J Cancer 2017. [DOI: 10.1016/s0959-8049(17)30271-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
46
|
Zanellato S, Musco A, Bruno A, Bassani B, Sampietro C, Cattoni M, Imperatori A, Albini A, Noonan D, Mortara L. Natural killer cells from patients with malignant or inflammatory pleural effusions display decreased cytotoxicity and a decidual NK-like phenotype. Eur J Cancer 2016. [DOI: 10.1016/s0959-8049(16)61745-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
47
|
Bruno A, Bassani B, D’Urso D, Boni L, Mortara L, Noonan D, Albini A. Tumour infiltrating (TINKs) and tumour associated (TANKs) natural killer cells: a new paradigm in colorectal cancer angiogenesis. Eur J Cancer 2016. [DOI: 10.1016/s0959-8049(16)61761-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
48
|
Dallaglio K, Romagnani A, Petrachi T, Grisendi G, Dominici M, Longo C, Argenziano G, Piana S, Albini A, Ciarrocchi A. 660 Phenformin targets the stem cell compartment in melanoma. J Invest Dermatol 2016. [DOI: 10.1016/j.jid.2016.02.701] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
49
|
Masini C, Bisagni A, Falco G, Bassano C, Baldi L, Bisagni G, Moretti G, Albini A, Boni C, Ferrari G, Gardini G. Relationship between levels of HER-2 amplification and pathologic complete response to trastuzumab-based neoadjuvant treatment. Ann Oncol 2015. [DOI: 10.1093/annonc/mdv336.36] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
50
|
Barbanti-Brodano G, Sampaolesi R, Campioni D, Lazzarin L, Altavilla G, Possati L, Masiello L, Benelli R, Albini A, Corallini A. HIV-1 tat acts as a growth factor and induces angiogenic activity in BK virus/tat transgenic mice. Antibiot Chemother (1971) 2015; 46:88-101. [PMID: 7529977 DOI: 10.1159/000423636] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
|